Showing 1 posts of 1 posts found.
Leading contract research organisations (CROs) reported a mixed bag of financial results for the first three months of 2010, although …
MHRA approves first lower-carbon beclometasone inhalers for asthma
Samsung Biologics launches bid to acquire peptide CDMO PolyPeptide
Novogenia breaks ground on personalised healthcare campus
InfectoPharm launches Polish operations with first hospital antibiotic
FibroFind appoints Lee Borthwick as CEO